These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9658575

  • 1. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
    Yatabe T, Kawai Y, Oku T, Tanaka H.
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):966-72. PubMed ID: 9658575
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.
    Phillips OA, Bosso MA, Ezeamuzie CI.
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1471-1482. PubMed ID: 32635785
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
    Hutchinson JH, Riendeau D, Brideau C, Chan C, Delorme D, Denis D, Falgueyret JP, Fortin R, Guay J, Hamel P.
    J Med Chem; 1993 Sep 17; 36(19):2771-87. PubMed ID: 8410991
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
    Musser JH, Kubrak DM, Chang J, Lewis AJ.
    J Med Chem; 1986 Aug 17; 29(8):1429-35. PubMed ID: 3090264
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of O-methyl and O-ethyl NSAID hydroxamic acids.
    Rajić Z, Perković I, Butula I, Zorc B, Hadjipavlou-Litina D, Pontiki E, Pepeljnjak S, Kosalec I.
    J Enzyme Inhib Med Chem; 2009 Oct 17; 24(5):1179-87. PubMed ID: 19772490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.
    Hamel P, Riendeau D, Brideau C, Chan CC, Desmarais S, Delorme D, Dubé D, Ducharme Y, Ethier D, Grimm E, Falgueyret JP, Guay J, Jones TR, Kwong E, McAuliffe M, McFarlane CS, Piechuta H, Roumi M, Tagari P, Young RN, Girard Y.
    J Med Chem; 1997 Aug 29; 40(18):2866-75. PubMed ID: 9288168
    [Abstract] [Full Text] [Related]

  • 13. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ.
    J Pharmacol Exp Ther; 1994 Dec 29; 271(3):1399-408. PubMed ID: 7996452
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A.
    Bioorg Med Chem; 2017 Aug 15; 25(16):4424-4432. PubMed ID: 28669741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM, Spruce KE, Crawley GC, Walker ER, Foster SJ.
    Br J Pharmacol; 1992 Dec 15; 107(4):1042-7. PubMed ID: 1334748
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, antioxidant and antiinflammatory activity of novel aryla-cetic and aryl-hydroxamic acids.
    Pontiki EA, Hadjipavlou-Litina DJ.
    Arzneimittelforschung; 2003 Dec 15; 53(11):780-5. PubMed ID: 14677374
    [Abstract] [Full Text] [Related]

  • 18. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities.
    Boschelli DH, Connor DT, Bornemeier DA, Dyer RD, Kennedy JA, Kuipers PJ, Okonkwo GC, Schrier DJ, Wright CD.
    J Med Chem; 1993 Jun 25; 36(13):1802-10. PubMed ID: 8515419
    [Abstract] [Full Text] [Related]

  • 19. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.
    Filosa R, Peduto A, Schaible AM, Krauth V, Weinigel C, Barz D, Petronzi C, Bruno F, Roviezzo F, Spaziano G, D'Agostino B, De Rosa M, Werz O.
    Eur J Med Chem; 2015 Apr 13; 94():132-9. PubMed ID: 25765759
    [Abstract] [Full Text] [Related]

  • 20. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS, Carlson RP, Grimes D, Howell R, Glaser K, Gunawan I, Nelson JA, Kanzelberger M, Shah U, Hartman DA.
    J Med Chem; 1996 Jan 05; 39(1):237-45. PubMed ID: 8568813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.